Understanding how a specific gene affects bone cell maturation and inflammation-related bone loss
Protocadherin 7 and Osteoclast Maturation
This study is looking at how a gene called Pcdh7 affects bone cells that break down bone, especially in conditions like gum disease, to help find new ways to prevent bone loss and improve treatment for people dealing with inflammation-related issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10990496 on NIH RePORTER |
What this research studies
This research investigates the role of a gene called Pcdh7 in the maturation of osteoclasts, which are cells responsible for bone resorption. By studying mice that lack this gene, researchers aim to uncover how Pcdh7 influences osteoclast function and its response to inflammation, particularly in conditions like periodontitis. The approach includes examining various biological markers and cellular functions related to osteoclast activity, which could lead to new therapeutic targets for preventing bone loss. Patients may benefit from insights gained about how to better manage inflammatory diseases that lead to bone destruction.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from inflammatory conditions that cause bone loss, such as periodontitis.
Not a fit: Patients with non-inflammatory bone loss conditions may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent bone loss in patients with inflammatory diseases.
How similar studies have performed: Other research has shown success in targeting cellular mechanisms related to bone health, making this approach promising yet still innovative.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Choi, Yongwon — University of Pennsylvania
- Study coordinator: Choi, Yongwon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.